Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000322336) titled 'Text message support versus group program for pain self-management in people with ongoing pain after early breast cancer (TEMPO-P study)' on March 13.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Northern Sydney Local Health District (NSLHD)
Condition:
Chronic pain
Early-stage breast cancer (survivorship phase)
Chronic pain
Early-stage breast cancer (survivorship phase)
Cancer - Breast
Anaesthesiology - Pain management
Intervention:
mHealth text messag...